{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:29:07Z","timestamp":1772623747463,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1124\/jpet.103.051714","type":"journal-article","created":{"date-parts":[[2003,8,19]],"date-time":"2003-08-19T01:20:33Z","timestamp":1061256033000},"page":"855-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"306","author":[{"given":"David S.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krys","family":"Bankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.051714_bib1","doi-asserted-by":"crossref","unstructured":"Ballard PA, Tetrud JW, and Langston JW (1985) Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35:949-956.","DOI":"10.1212\/WNL.35.7.949"},{"key":"10.1124\/jpet.103.051714_bib2","doi-asserted-by":"crossref","unstructured":"Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, and Kopin IJ (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39:7-16.","DOI":"10.1016\/0024-3205(86)90431-5"},{"key":"10.1124\/jpet.103.051714_bib3","doi-asserted-by":"crossref","unstructured":"Berding G, Schrader CH, Peschel T, Van Den Hoff J, Kolbe H, Meyer GJ, Dengler R, and Knapp WH (2003) N-Methyl (11)C]meta-hydroxyephedrine positron emission tomography in Parkinson\u2019s disease and multiple system atrophy. Eur J Nucl Med Mol Imaging 30:127-131.","DOI":"10.1007\/s00259-002-1019-7"},{"key":"10.1124\/jpet.103.051714_bib4","doi-asserted-by":"crossref","unstructured":"Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, and Lucking CH (1998) Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson\u2019s disease with autonomic failure. Acta Neurol Scand 97:307-314.","DOI":"10.1111\/j.1600-0404.1998.tb05958.x"},{"key":"10.1124\/jpet.103.051714_bib5","doi-asserted-by":"crossref","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, and Lucking CH (1999) Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology 53:1020-1025.","DOI":"10.1212\/WNL.53.5.1020"},{"key":"10.1124\/jpet.103.051714_bib6","doi-asserted-by":"crossref","unstructured":"Chang PC, Szemeredi K, Grossman E, Kopin IJ, and Goldstein DS (1990) Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function. J Pharmacol Exp Ther 255:809-817.","DOI":"10.1016\/S0022-3565(25)23160-3"},{"key":"10.1124\/jpet.103.051714_bib7","doi-asserted-by":"crossref","unstructured":"Cordes M, Snow BJ, Cooper S, Schulzer M, Pate BD, Ruth TJ, and Calne DB (1994) Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Ann Neurol 36:667-670.","DOI":"10.1002\/ana.410360420"},{"key":"10.1124\/jpet.103.051714_bib8","doi-asserted-by":"crossref","unstructured":"Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, Druschky K, Kuwert T, and Neundorfer B (2000) Differentiation of Parkinson\u2019s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 175: 3-12.","DOI":"10.1016\/S0022-510X(00)00279-3"},{"key":"10.1124\/jpet.103.051714_bib9","doi-asserted-by":"crossref","unstructured":"Eberling JL, Bankiewicz KS, Jordan S, VanBrocklin HF, and Jagust WJ (1997) PET studies of functional compensation in a primate model of Parkinson\u2019s disease. Neuroreport 8:2727-2733.","DOI":"10.1097\/00001756-199708180-00017"},{"key":"10.1124\/jpet.103.051714_bib10","doi-asserted-by":"crossref","unstructured":"Elsworth JD, Taylor JR, Sladek JR Jr, Collier TJ, Redmond DE Jr, and Roth RH (2000) Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 95:399-408.","DOI":"10.1016\/S0306-4522(99)00437-6"},{"key":"10.1124\/jpet.103.051714_bib11","doi-asserted-by":"crossref","unstructured":"Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, and Jennings G (1991) Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 260:R817-R823.","DOI":"10.1152\/ajpregu.1991.260.4.R817"},{"key":"10.1124\/jpet.103.051714_bib12","doi-asserted-by":"crossref","unstructured":"Finberg J, Dibner-Dunlap M, Yuih SN, and Thames MD (1990) Effects of desipra-mine hydrochloride on peripheral sympathetic nerve activity. Am J Physiol 258:R876-R882.","DOI":"10.1152\/ajpregu.1990.258.4.R876"},{"key":"10.1124\/jpet.103.051714_bib13","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J, Kirk KL, Bacharach S, and Kopin IJ (1990) Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 81:1606-1621.","DOI":"10.1161\/01.CIR.81.5.1606"},{"key":"10.1124\/jpet.103.051714_bib14","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Eisenhofer G, Dunn BB, Armando I, Lenders J, Grossman E, Holmes C, Kirk KL, Bacharach S, Adams R, et al. (1993) Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans. J Am Coll Cardiol 22:1961-1971.","DOI":"10.1016\/0735-1097(93)90786-Z"},{"key":"10.1124\/jpet.103.051714_bib15","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Grossman E, Tamrat M, Chang PC, Eisenhofer G, Bacher J, Kirk KL, Bacharach S, and Kopin IJ (1991) Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. J Hypertens 9:417-423.","DOI":"10.1097\/00004872-199105000-00005"},{"key":"10.1124\/jpet.103.051714_bib16","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Holmes C, Cannon RO 3rd, Eisenhofer G, and Kopin IJ (1997a) Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336:696-702.","DOI":"10.1056\/NEJM199703063361004"},{"key":"10.1124\/jpet.103.051714_bib17","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Holmes C, Dendi R, Bruce S, and Li S-T (2002) Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58:1247-1255.","DOI":"10.1212\/WNL.58.8.1247"},{"key":"10.1124\/jpet.103.051714_bib18","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, and Cannon RO (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338-347.","DOI":"10.7326\/0003-4819-133-5-200009050-00009"},{"key":"10.1124\/jpet.103.051714_bib19","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Holmes C, Stuhlmuller JE, Lenders JWM, and Kopin IJ (1997b) 6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function-studies in normal humans. Clin Auton Res 7: 17-29.","DOI":"10.1007\/BF02267622"},{"key":"10.1124\/jpet.103.051714_bib20","doi-asserted-by":"crossref","unstructured":"Holmes C, Eisenhofer G, and Goldstein DS (1994) Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 653:131-138.","DOI":"10.1016\/0378-4347(93)E0430-X"},{"key":"10.1124\/jpet.103.051714_bib21","doi-asserted-by":"crossref","unstructured":"Kaye DM, Esler M, Kingwell B, McPherson G, Esmore D, and Jennings G (1993) Functional and neurochemical evidence for partial cardiac sympathetic reinnervation after cardiac transplantation in humans. Circulation 88:1110-1118.","DOI":"10.1161\/01.CIR.88.3.1110"},{"key":"10.1124\/jpet.103.051714_bib22","doi-asserted-by":"crossref","unstructured":"Langston JW and Ballard PA Jr (1983) Parkinson\u2019s disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 309:310.","DOI":"10.1056\/NEJM198308043090511"},{"key":"10.1124\/jpet.103.051714_bib23","doi-asserted-by":"crossref","unstructured":"Langston JW, Ballard PA, Tetrud JW, and Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science (Wash DC) 219:979-980.","DOI":"10.1126\/science.6823561"},{"key":"10.1124\/jpet.103.051714_bib24","doi-asserted-by":"crossref","unstructured":"Lavian G, Di Bona G, and Finberg JPM (1991) Inhibition of sympathetic nerve activity by acute administration of the tricyclic antidepressant desipramine. Eur J Pharmacol 194:153-159.","DOI":"10.1016\/0014-2999(91)90099-C"},{"key":"10.1124\/jpet.103.051714_bib25","doi-asserted-by":"crossref","unstructured":"Li ST, Dendi R, Holmes C, and Goldstein DS (2002) Progressive loss of cardiac sympathetic innervation in Parkinson\u2019s disease. Ann Neurol 52:220-223.","DOI":"10.1002\/ana.10236"},{"key":"10.1124\/jpet.103.051714_bib26","doi-asserted-by":"crossref","unstructured":"Luthman J and Sundstrom E (1990) No apparent difference in the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the sympathetic system in NMRI and C57 BL\/6 mice. Toxicol Lett 54:83-92.","DOI":"10.1016\/0378-4274(90)90059-U"},{"key":"10.1124\/jpet.103.051714_bib27","unstructured":"Ohmura M (2000) Loss of 123I-MIBG uptake by the heart in Parkinson\u2019s disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 41:1594-1595."},{"key":"10.1124\/jpet.103.051714_bib28","doi-asserted-by":"crossref","unstructured":"Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, Nagao T, and Yokochi M (2002) Sympathetic cardiac denervation in Parkinson\u2019s disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 73:776-777.","DOI":"10.1136\/jnnp.73.6.776"},{"key":"10.1124\/jpet.103.051714_bib29","doi-asserted-by":"crossref","unstructured":"Orimo S, Ozawa E, Oka T, Nakade S, Tsuchiya K, Yoshimoto M, Wakabayashi K, and Takahashi H (2001) Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 57:1140-1141.","DOI":"10.1212\/WNL.57.6.1140"},{"key":"10.1124\/jpet.103.051714_bib30","doi-asserted-by":"crossref","unstructured":"Reinhardt MJ, Jungling FD, Krause TM, and Braune S (2000) Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake. Eur J Nucl Med 27:595-600.","DOI":"10.1007\/s002590050548"},{"key":"10.1124\/jpet.103.051714_bib31","unstructured":"Satoh A, Serita T, Seto M, Tomita I, Satoh H, Iwanaga K, Takashima H, and Tsujihata M (1999) Loss of 123I-MIBG uptake by the heart in Parkinson\u2019s disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 40:371-375."},{"key":"10.1124\/jpet.103.051714_bib32","unstructured":"Satoh A, Serita T, and Tsujihata M (1997) Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson\u2019s disease: assessment of cardiac sympathetic denervation. Nippon Rinsho 55:202-206."},{"key":"10.1124\/jpet.103.051714_bib33","doi-asserted-by":"crossref","unstructured":"Senard JM, Rascol O, Durrieu G, Tran MA, Berlan M, Rascol A, and Montastruc JL (1993) Effects of yohimbine on plasma catecholamine levels in orthostatic hypo-tension related to Parkinson disease or multiple system atrophy. Clin Neuropharmacol 16: 70-76.","DOI":"10.1097\/00002826-199302000-00008"},{"key":"10.1124\/jpet.103.051714_bib34","doi-asserted-by":"crossref","unstructured":"Skirboll S, Wang J, Mefford I, Hsiao J, and Bankiewicz KS (1990) In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis. Exp Neurol 110:187-193.","DOI":"10.1016\/0014-4886(90)90029-R"},{"key":"10.1124\/jpet.103.051714_bib35","doi-asserted-by":"crossref","unstructured":"Stoddard SL, Merkel GJ, Cook JA, Zinsmeister AR, and Carmichael SW (1994) Adrenal medulla and Parkinson\u2019s disease. Microsc Res Tech 29:151-154.","DOI":"10.1002\/jemt.1070290212"},{"key":"10.1124\/jpet.103.051714_bib36","doi-asserted-by":"crossref","unstructured":"Szabo B and Schultheiss A (1990) Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 342:469-476.","DOI":"10.1007\/BF00169466"},{"key":"10.1124\/jpet.103.051714_bib37","unstructured":"Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, Noda T, Nishigaki K, and Fujiwara H (2000) Cardiac sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radio-labeled MIBG. J Nucl Med 41:71-77."},{"key":"10.1124\/jpet.103.051714_bib38","doi-asserted-by":"crossref","unstructured":"Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, Sakajiri K, and Tonami N (2000) Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566-573.","DOI":"10.1007\/s002590050544"},{"key":"10.1124\/jpet.103.051714_bib39","doi-asserted-by":"crossref","unstructured":"Vingerhoets FJ, Snow BJ, Tetrud JW, Langston JW, Schulzer M, and Calne DB (1994) Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 36:765-770.","DOI":"10.1002\/ana.410360513"},{"key":"10.1124\/jpet.103.051714_bib40","doi-asserted-by":"crossref","unstructured":"Yoshita M, Hayashi M, and Hirai S (1998) Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson\u2019s disease. Nucl Med Commun 19:137-142.","DOI":"10.1097\/00006231-199802000-00007"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524308778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524308778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.051714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:29:59Z","timestamp":1739975399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524308778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0022356524308778"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.051714","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.051714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}